Director/PDMR Shareholding

RNS Number : 7244K
AstraZeneca PLC
01 August 2013
 



Transactions by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

 

On 1 August 2013, Marc Dunoyer, EVP, Global Portfolio & Product Strategy, a person discharging managerial responsibilities, was granted awards under the terms of the AstraZeneca Investment Plan (AZIP), the AstraZeneca Performance Share Plan (AZPSP) and the AstraZeneca Restricted Share Plan (AZRSP) over the Company's Ordinary Shares of US$0.25 each.  A summary of these plans can be found in the AstraZeneca Annual Report and Form 20-F Information 2012 which is available on the Company's website www.astrazeneca.com.

 

 

Name

Shares awarded under AZIP

Shares awarded under AZPSP

Shares awarded under AZRSP

Award price per share

 

Marc Dunoyer

 

8,176

 

90,853

 

65,505

 

3302p

 

The AZIP award is subject to a four-year performance period (1 January 2013 to 31 December 2016) and a subsequent four-year holding period (1 January 2017 to 31 December 2020).

 

The AZPSP award is subject to a three-year performance period (1 January 2013 to 31 December 2015).

 

More information about the performance measures that relate to the AZIP and the AZPSP awards is set out in the Remuneration Committee Chairman's Speech and Presentation which was presented to shareholders at the Company's 2013 AGM, and which can be found at www.astrazeneca.com/Investors/Shareholder-information/Annual-General-Meeting.

 

The AZRSP award will vest as follows:

 

9,103 shares will vest on 15 June 2014 subject to Mr Dunoyer's continued employment with the Company

41,472 shares will vest on 15 June 2015 subject to Mr Dunoyer's continued employment with the Company

14,930 shares will vest on 1 August 2016 subject to the same performance conditions as the AZPSP award

 

Mr Dunoyer commenced employment with the Company on 15 June 2013.  All of the awards, which were approved by the Remuneration Committee, result from a combination of the normal operation of the Company's long-term incentive plans for 2013 and arrangements to compensate Mr Dunoyer for the forfeiture of unvested long-term incentive awards from his previous employer.

 

A C N Kemp

Company Secretary

1 August 2013

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUAARRORAWRAR

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings